This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Iordanov, M. S. Articles by Magun, B. E. Search for Related Content PubMed PubMed Citation Articles by Iordanov, M. S. Articles by Magun, B. E.

Molecular Determinants of Apoptosis Induced by the Cytotoxic Ribonuclease Onconase: Evidence for Cytotoxic Mechanisms Different from Inhibition of Protein Synthesis¹

Department of Cell and Developmental Biology, Oregon Health Sciences University, Portland, Oregon 97201 [M. S. I., O. P. R., J. W., T-H. D., B. E. M.], and Intramural Research Support Program, Science Applications International Corporation Frederick [D. L. N.] and Laboratory of Drug Discovery, Research and Development, Developmental Therapeutics Program, Division of Cancer Treatment and Diagnosis [S. M. R.], National Cancer Institute-Frederick Cancer Research and Development Center, Frederick, Maryland 21702

Cytotoxic endoribonucleases (RNases) possess a potential for use in cancer therapy. However, the molecular determinants of RNase-induced cell death are not well understood. In this work, we identify such determinants of the cytotoxicity induced by onconase, an amphibian cytotoxic RNase. Onconase displayed a remarkable specificity for tRNA in vivo, leaving rRNA and mRNA apparently undamaged. Onconase-treated cells displayed apoptosis-associated cell blebbing, nuclear pyknosis and fragmentation (karyorrhexis), DNA fragmentation, and activation of caspase-3-like activity. The cytotoxic action of onconase correlated with inhibition of protein synthesis; however, we present evidence for the existence of a mechanism of onconase-induced apoptosis that is independent of inhibition of protein synthesis. The caspase inhibitor benzyloxycarbonyl-Val-Ala-Asp(OMe) fluoromethyl ketone (zVADfmk), at concentrations that completely prevent apoptosis and caspase activation induced by ligation of the death receptor Fas, had only a partial protective effect on onconase-induced cell death. The proapoptotic activity of the p53 tumor suppressor protein and the Fas ligand/Fas/Fas-associating protein with death domain (FADD)/caspase-8 proapoptotic cascade were not required for onconase-induced apoptosis. Procaspases-9, -3, and -7 were processed in onconase-treated cells, suggesting the involvement of the mitochondrial apoptotic machinery in onconase-induced apoptosis. However, the onconase-induced activation of the caspase-9/caspase-3 cascade correlated with atypically little release of cytochrome c from mitochondria. In turn, the low levels of cytochrome c released from mitochondria correlated with a lack of detectable translocation of proapoptotic Bax from the cytosol onto mitochondria in response to onconase. This suggests the possibility of involvement of a different, potentially Bax- and cytochrome c-independent mechanism of caspase-9 activation in onconase-treated cells. As one possible mechanism, we demonstrate that procaspase-9 is released from mitochondria in onconase-treated cells. A detailed understanding of the molecular determinants of the cytotoxic action of onconase could provide means of positive or negative therapeutic modulation of the activity of this potent anticancer agent.

This article has been cited by other articles:

				S. Yamasaki, P. Ivanov, G.-f. Hu, and P. Anderson Angiogenin cleaves tRNA and promotes stress-induced translational repression J. Cell Biol., April 6, 2009; 185(1): 35 - 42. [Abstract] [Full Text] [PDF]

				D. M. Thompson, C. Lu, P. J. Green, and R. Parker tRNA cleavage is a conserved response to oxidative stress in eukaryotes RNA, October 1, 2008; 14(10): 2095 - 2103. [Abstract] [Full Text] [PDF]

				R. Stein, M. J. Mattes, T. M. Cardillo, H. J. Hansen, C.-H. Chang, J. Burton, S. Govindan, and D. M. Goldenberg CD74: A New Candidate Target for the Immunotherapy of B-Cell Neoplasms Clin. Cancer Res., September 15, 2007; 13(18): 5556s - 5563s. [Abstract] [Full Text] [PDF]

				M. Rodriguez, G. Torrent, M. Bosch, F. Rayne, J.-F. Dubremetz, M. Ribo, A. Benito, M. Vilanova, and B. Beaumelle Intracellular pathway of Onconase that enables its delivery to the cytosol J. Cell Sci., April 15, 2007; 120(8): 1405 - 1411. [Abstract] [Full Text] [PDF]

				C.-H. Chang, P. Sapra, S. S. Vanama, H. J. Hansen, I. D. Horak, and D. M. Goldenberg Effective therapy of human lymphoma xenografts with a novel recombinant ribonuclease/anti-CD74 humanized IgG4 antibody immunotoxin Blood, December 15, 2005; 106(13): 4308 - 4314. [Abstract] [Full Text] [PDF]

				M. E. Ramos-Nino, G. Vianale, T. Sabo-Attwood, L. Mutti, C. Porta, N. Heintz, and B. T. Mossman Human mesothelioma cells exhibit tumor cell-specific differences in phosphatidylinositol 3-kinase/AKT activity that predict the efficacy of Onconase Mol. Cancer Ther., May 1, 2005; 4(5): 835 - 842. [Abstract] [Full Text] [PDF]

				D. Spalletti-Cernia, R. Sorrentino, S. Di Gaetano, A. Arciello, C. Garbi, R. Piccoli, G. D'Alessio, G. Vecchio, P. Laccetti, and M. Santoro Antineoplastic Ribonucleases Selectively Kill Thyroid Carcinoma Cells Via Caspase-Mediated Induction of Apoptosis J. Clin. Endocrinol. Metab., June 1, 2003; 88(6): 2900 - 2907. [Abstract] [Full Text] [PDF]

				T. Hoshino, S. Tsutsumi, W. Tomisato, H.-J. Hwang, T. Tsuchiya, and T. Mizushima Prostaglandin E2 Protects Gastric Mucosal Cells from Apoptosis via EP2 and EP4 Receptor Activation J. Biol. Chem., April 4, 2003; 278(15): 12752 - 12758. [Abstract] [Full Text] [PDF]

				S. M. Mikulski, J. J. Costanzi, N. J. Vogelzang, S. McCachren, R. N. Taub, H. Chun, A. Mittelman, T. Panella, C. Puccio, R. Fine, et al. Phase II Trial of a Single Weekly Intravenous Dose of Ranpirnase in Patients With Unresectable Malignant Mesothelioma J. Clin. Oncol., January 1, 2002; 20(1): 274 - 281. [Abstract] [Full Text] [PDF]

				D. L. Newton, H. J. Hansen, S. M. Mikulski, D. M. Goldenberg, and S. M. Rybak Potent and specific antitumor effects of an anti-CD22-targeted cytotoxic ribonuclease: potential for the treatment of non-Hodgkin lymphoma Blood, January 15, 2001; 97(2): 528 - 535. [Abstract] [Full Text] [PDF]

				M. S. Iordanov, J. Wong, J. C. Bell, and B. E. Magun Activation of NF-{kappa}B by Double-Stranded RNA (dsRNA) in the Absence of Protein Kinase R and RNase L Demonstrates the Existence of Two Separate dsRNA-Triggered Antiviral Programs Mol. Cell. Biol., January 1, 2001; 21(1): 61 - 72. [Abstract] [Full Text]

				Y.-D. Liao, H.-C. Huang, Y.-J. Leu, C.-W. Wei, P.-C. Tang, and S.-C. Wang Purification and cloning of cytotoxic ribonucleases from Rana catesbeiana (bullfrog) Nucleic Acids Res., November 1, 2000; 28(21): 4097 - 4104. [Abstract] [Full Text] [PDF]

				S.-l. Chen, S.-Y. Le, D. L. Newton, J. V. M. Jr, and S. M. Rybak A gender-specific mRNA encoding a cytotoxic ribonuclease contains a 3' UTR of unusual length and structure Nucleic Acids Res., June 15, 2000; 28(12): 2375 - 2382. [Abstract] [Full Text] [PDF]